- ►diabetesjournals.org SA Amiel, PE Cryer - Diabetes, 2009 - Am Diabetes Assoc Hypoglycemia in diabetes is fundamentally the result of episodes of therapeutic hyperinsulinemia
caused by treatment with an insulin secretagogue or insulin. In general, the incidence of iatrogenic
hypoglycemia is a function of the degree of β-cell failure (1,2,4), and risk is predicted by ... Related articles - All 4 versions
- ►diabetesjournals.org SN Davis, S Mann, VJ Briscoe, AC Ertl, DB Tate - Diabetes, 2009 - Am Diabetes Assoc OBJECTIVE—The physiology of counterregulatory responses during hypoglycemia in intensively
treated type 2 diabetic subjects is largely unknown. Therefore, the specific aims of the study tested
the hypothesis that 1) 6 months of intensive therapy to lower A1C <7.0% would blunt ... Cited by 3 - Related articles - All 9 versions
- ►diabetesjournals.org GK Adler, I Bonyhay, H Failing, E Waring, S Dotson, R … - Diabetes, 2009 - Am Diabetes Assoc OBJECTIVE— Glycemic control decreases the incidence and progression of diabetic complications
but increases the incidence of hypoglycemia. Hypoglycemia can impair hormonal and autonomic
responses to subsequent hypoglycemia. Intensive glycemic control may increase ... Cited by 3 - Related articles - All 3 versions
- ►shouxi.net VJ Briscoe, SN Davis - Clinical Diabetes, 2006 - Am Diabetes Assoc Donnelly et al. 13 randomly surveyed individuals (n = 267) with type 1 diabetes and insulin-treated
type 2 diabetes to prospectively record hypoglycemic events encountered over a 4-week
period. Of the 267 subjects, 155 reported 572 incidents of hypoglycemia. The type 1 ... Cited by 21 - Related articles - BL Direct - All 6 versions
- ►insulinjournal.com [PDF] PE Cryer, IE, MM Karl - Insulin, 2007 - Elsevier Results: Glycemic defenses become compromised rapidly in type 1 DM but slowly in type 2
DM. As a result, the frequency of hypoglycemia increases progressively as patients approach
the insulin-deficient end of the spectrum of type 2 DM. Indeed, it appears that most ... Related articles - All 3 versions
- ►diabetesjournals.org PE Cryer - Diabetes, 2008 - Am Diabetes Assoc Glycemic control, a worthwhile goal for people with diabetes, is limited by the barrier of iatrogenic
hypoglycemia (1). Iatrogenic hypoglycemia 1) causes recurrent morbidity in most people with
type 1 diabetes and many with advanced type 2 diabetes and is sometimes fatal, 2) ... Cited by 16 - Related articles - All 3 versions
PE Cryer - Type 2 Diabetes Mellitus: An Evidence-Based …, 2008 - Springer Summary Iatrogenic hypoglycemia is the limiting factor in the glycemic management of
diabetes. It can be caused by sulfonylureas or other insulin secretagogues, and perhaps by
metformin, as well as by insulin. Hypoglycemia is less frequent overall in type 2 diabetes ( ... Related articles - All 2 versions
S Banarer, PE Cryer - Medical Clinics of North America, 2004 - Elsevier Glycemic control makes a difference for people with type 1 (T1) [1] and 2 (T2) [2 and 3] diabetes
mellitus (DM), but the barrier of hypoglycemia precludes true glycemic control, that is, maintenance
of euglycemia over a lifetime of diabetes, and thus full realization of its established ... Cited by 17 - Related articles - BL Direct - All 3 versions
D Hopkins - Diabetes research and clinical practice, 2004 - Elsevier Daytime hypoglycemia, like its nocturnal counterpart, is a practical barrier to achieving optimal
glycemic control in type 1 diabetes. Daytime hypoglycemia also causes serious social disruptions
for people with diabetes because it interferes with daily activities such as working, ... Cited by 9 - Related articles - All 3 versions
- ►diabetesjournals.org BB Dokken - Diabetes Spectrum, 2008 - Am Diabetes Assoc The results of three recent trials, the Action to Control Cardiovascular Risk in Diabetes
(ACCORD) trial, the Action in Diabetes and Vascular Disease (ADVANCE) trial, and the Veterans
Affairs Diabetes Trial (VADT), indicate that lower blood glucose levels are not always ... Related articles - All 2 versions
